The biotech industry is continuously faced with challenges. This is particularly
so for the emerging, innovative biotech seeking to fund projects. MedImmune
Ventures was formed to help these visionaries translate scientific discovery
into exciting treatments that can benefit patients around the globe.
Notable investments
MedImmune Ventures has already supported a portfolio of more than 25 companies,
such as:
-
Ambit Biosciences
-
Applied Genetic Technologies Corporation
-
Arginetix
-
BrainCells, Inc.
-
Elusys Therapeutics, Inc.
-
Hydra Biosciences
-
Inotek Pharmaceuticals Corporation
-
LigoCyte Pharmaceuticals, Inc.
-
Micromet, Inc.
-
NKT Therapeutics, Inc.
-
Rib-X Pharmaceuticals, Inc.
-
Sequoia Pharmaceuticals, Inc.
-
VaxInnate Corporation
-
Virdante Pharmaceuticals
-
VLST Corporation
-
Xencor, Inc.
To learn more about each company, visit our Ventures
Portfolio section.